Micro-nanoprojection patches for minimally-invasive and targeted delivery of genes and drugs to skin cells: from concept to technology platform

用于将基因和药物微创、定向递送至皮肤细胞的微纳米投影贴片：从概念到技术平台

• 批准号: DP0774647
• 负责人: Prof Mark Kendall
• 金额: $ 46.83万
• 依托单位: The University of Queensland
• 依托单位国家: 澳大利亚
• 项目类别: Discovery Projects
• 财政年份: 2007
• 资助国家: 澳大利亚
• 起止时间: 2007-01-01 至 2009-12-31
• 项目状态: 已结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/DP0774647
• 关键词: Micro; nanoprojection; patches; minimally; invasive

This project will address key science questions on the recently patented micro-nanoprojections patch, establishing it in Australia as a world leading technology in the rapidly growing and important field of gene and drug delivery. Unique internationally-competitive science outcoumes and research training will be generated at the interfaces between bioengineering, nanotechnology, pharmaceutical science and immunology. Ultimately, the project will allow improved treatment of major diseases (e.g. vaccination and immunotherapy of asthma). Achieving these health benefits by commercial pathways is expected to benefit the Australian community and emerging Biotechnology industry-creating highly valued career opportunities for Australians.

该项目将解决最近获得专利的微纳米投影贴片的关键科学问题，使其在澳大利亚成为基因和药物输送领域快速增长和重要领域的世界领先技术。独特的国际竞争力的科学outcoumes和研究培训将在生物工程，纳米技术，制药科学和免疫学之间的接口产生。最终，该项目将改善重大疾病的治疗（如哮喘的疫苗接种和免疫治疗）。通过商业途径实现这些健康益处预计将使澳大利亚社区和新兴的生物技术行业受益，为澳大利亚人创造极具价值的职业机会。